Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay
Background: Lipoprotein particles with abnormal compositions, such as lipoprotein X (LP-X) and lipoprotein Z (LP-Z), have been described in cases of obstructive jaundice and cholestasis. The study objectives were to: (1) develop an NMR-based assay for quantification of plasma/serum LP-Z particles, (...
Main Authors: | Shimpi Bedi, Erwin Garcia, Elias J. Jeyarajah, Irina Shalaurova, Maria Camila Perez-Matos, Z. Gordon Jiang, Robin P. F. Dullaart, Steven P. Matyus, William J. Kirk, James D. Otvos, W. Sean Davidson, Margery A. Connelly |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/9/2915 |
Similar Items
-
A High-Throughput NMR Method for Lipoprotein-X Quantification
by: Erwin Garcia, et al.
Published: (2024-01-01) -
A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X
by: Edward B. Neufeld, et al.
Published: (2022-08-01) -
Lipoprotein a - Lp(a)
by: Tapan Ghose
Published: (2024-03-01) -
A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort
by: Jose L. Flores-Guerrero, et al.
Published: (2020-08-01) -
Nut consumption is associated with a shift of the NMR lipoprotein subfraction profile to a less atherogenic pattern among older individuals at high CVD risk
by: Jesús F. García-Gavilán, et al.
Published: (2022-09-01)